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Risk factors of postoperative complications 
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S t u d y  a i m.  The aims of the study were: 1. Evaluation of factors increasing the risk of complications after total or subtotal
gastric resection for gastric cancer, 2. Attempt to evaluate changes in perioperative management that should decrease the
complication risk after curative surgical treatment in gastric cancer patients.
Pa t i e n t s  a n d  m e t h o d s.  The series includes 253 patients with gastric cancer who were prospectively followed up from
1988 to 2001. Detailed evaluation covered 132 patients in whom radical operations were performed. Analysed factors were:
age, gender, nutritional status, stage, pathology of regional lymph nodes, operating time, type of surgery, stapler use, preoperative
and postoperative nutritional support. Relations between each factor and general or surgical complications incidence were
analyzed.
R e s u l t s.  Postoperative complications occurred in 63 patients (47.7%) – surgical complications in 33 (25%) and general
complications in 51 (38.6%). Both types of complications occurred in 21 patients (15.9%). Oesophago-intestinal anastomosis
leakage occurred in 9 patients (6.8%). Statistically significant differences in general complication number were seen between
the N0 and the N1/N2 group (p=0.02). General complications were more frequent in the patients with subcardial tumor
localisation (p=0.01). The higher frequency of surgical complications in the patients in whom total gastric resection was made
comparing to the groups in whom other resections were made was statistically significant (p=0.05). In patients in whom
splenectomy was additionally made (33 patients) the total complication number was clearly higher (26/33). Parenteral
nutrition in the postoperative period significantly influenced the occurrence of general complications (p=0.0057). There was
a statistically (p=0.05) difference between the mean age of patients with major general complications and the mean age of
patients with minor general complications. Patients with major general complications were significantly older - by 8 years on
average. Significant difference (p=0.05) was seen in mean BMI of patients with minor surgical complications and patients
without surgical complications. There was also significant difference in surgical procedure duration in patients with major
surgical complications and those without surgical complications (p=0.01), as well as a difference in the surgical procedure
duration in patients with minor general complications and those without general complications (p=0.05).
C o n c l u s i o n.  As a result of prospective follow-up of patients with gastric cancer who underwent curative resection, the
following conclusions were made: 1) Regional lymph node involvement (N1/N2), subcardial tumor location, high BMI, age,
range and duration of surgical procedure significantly influenced the number of general and surgical complications 2)
Stapler use caused improvement in surgical technique, but had no significant influence on the decrease in the number of
surgical postoperative complications. 3) Parenteral nutrition in the postoperative period may increase the risk of general
complications. 4) Comprehensive management aimed at minimising perioperative complications should include adequate
preoperative and postoperative nutritional support, antibiotic and anticoagulant prophylactics, rationalisation of operation
duration, good oncological justification for expanding the procedure to splenectomy and lymphadenectomy D3, which
increase the number of complications and careful monitoring during the postoperative period, which requires knowledge of
surgical characteristics.
Czynniki ryzyka powik∏aƒ pooperacyjnych po zabiegach z intencjà wyleczenia w raku ˝o∏àdka
C e l.  Celem pracy by∏y: ocena czynników zwi´kszajàcych ryzyko powik∏aƒ po ca∏kowitym lub prawie ca∏kowitym wyci´ciu ˝o-
∏àdka z powodu raka, próba oceny zmiany zasad post´powania oko∏ooperacyjnego, zmniejszajàcego ryzyko powik∏aƒ po do-
szcz´tnym leczeniu chirurgicznym u chorych z rakiem ˝o∏àdka.
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Introduction
Despite a fall in the incidence of gastric cancer noted
in the last few years it still remains one of the most
common malignancies recognised in the Polish populace.
Over 90% of cases recognised in Poland are advanced,
which negatively effects treatment results. The standard
oncological treatment performed with a curative intent
is surgical excision of the stomach with regional lymph
nodes (gastrectomia fere totalis/totalis cum lymphadene-
ctomia regionali). In Poland some 50-70% of patients
qualify for this procedure. Radical surgery performed for
gastric cancer carries a high risk of postoperative compli-
cations, including perioperative mortality, which explains
the need to search for treatment methods which would
limit both the risk of complications and the mortality.
Study aim
The aims of the study were:
1. To evaluate the risk factors of complications after total
or subtotal gastric resection for gastric cancer
2. To investigate, whether changes in perioperative
management may decrease the complication risk after
curative surgical treatment of gastric cancer patients.
Material and method
The series included 253 gastric cancer patients, prospectively
followed-up from 1988 to 2001.
Detailed prospective evaluation was performed in 132
patients who had undergone radical operations.
During the premedication (30-45 min before surgery)
patients received antibiotic prophylaxis (cephalosporin I gene-
ration & metronidazole i.v.) and antithrombotic prophylaxis
(low molecular weight heparin s.c.). The peritoneum was opened
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M a t e r i a ∏  i m e t o d y.  Materia∏ stanowi∏o 253 chorych z rakiem ˝o∏àdka z lat 1988–2001, obserwowanych prospektywnie.
Szczegó∏owej ocenie poddano 132 chorych, u których wykonano doszcz´tne zabiegi operacyjne. U chorych tych analizie
poddano szereg parametrów: wiek, p∏eç, stan od˝ywienia, stopieƒ klinicznego zaawansowania nowotworu wg klasyfikacji TNM,
stan histologiczny regionalnych w´z∏ów ch∏onnych, czas trwania zabiegu operacyjnego, rodzaj wykonanego zabiegu operacyj-
nego (ca∏kowite lub prawie ca∏kowite wyci´cie ˝o∏àdka, rodzaj zespolenia prze∏ykowo-jelitowego), koniecznoÊç poszerzenia za-
biegu operacyjnego o wyci´cie innych narzàdów, u˝ycie staplerów, stosowanie leczenia ˝ywieniowego – przedoperacyjnego i po-
operacyjnego. Poddano analizie statystycznej zale˝noÊç pomi´dzy poszczególnymi parametrami, a cz´stoÊcià wyst´powania po-
wik∏aƒ chirurgicznych i ogólnych.
W y n i k i.  Powik∏ania pooperacyjne wystàpi∏y u 63 chorych (47,7%) – chirurgiczne u 33 (25%), ogólne u 51 (38,6%). Oba
rodzaje powik∏aƒ – chirurgiczne i ogólne jednoczeÊnie – wystàpi∏y u 21 chorych (15,9%). Najgroêniejsze z pooperacyjnych po-
wik∏aƒ chirurgicznych – nieszczelnoÊç zespolenia prze∏ykowo-jelitowego – wystàpi∏o u 9 chorych po ca∏kowitym wyci´ciu ˝o-
∏àdka (6,8%). Istotne statystycznie by∏y ró˝nice w iloÊci obserwowanych powik∏aƒ ogólnych pomi´dzy grupà chorych N0, a gru-
pà chorych N1/N2 (p=0,02). Powik∏ania ogólne wyst´powa∏y cz´Êciej w grupie chorych z podwpustowà lokalizacjà guza
(p=0,01). Wi´ksza cz´stoÊç wyst´powania powik∏aƒ chirurgicznych w grupie chorych po ca∏kowitym wyci´ciu ˝o∏àdka,
w porównaniu z grupami chorych po innych rodzajach wyci´ç ˝o∏àdka, by∏a istotna statystycznie (p=0,05). W grupie chorych,
u których jako zabieg dodatkowy wykonano wyci´cie Êledziony (33 chorych), ogólna liczba powik∏aƒ by∏a wyraênie wy˝sza
w porównaniu z grupà chorych, u których wykonano inne zabiegi dodatkowe (26/33). ˚ywienie pozajelitowe w okresie poope-
racyjnym mia∏o istotny wp∏yw na wystàpienie powik∏aƒ ogólnych (p=0,0057). Istotna statystycznie (p=0,05) by∏a ró˝nica Êred-
niego wieku pomi´dzy chorymi z „du˝ymi” powik∏aniami ogólnymi i chorymi z „ma∏ymi” powik∏aniami ogólnymi: chorzy,
u których obserwowano „du˝e” powik∏ania ogólne byli starsi Êrednio o 8 lat. Istotna statystycznie (p=0,05) by∏a ró˝nica po-
mi´dzy Êrednimi wartoÊciami BMI chorych z „ma∏ymi” powik∏aniami chirurgicznymi i chorych bez powik∏aƒ chirurgicznych
oraz ró˝nica pomi´dzy Êrednimi wartoÊciami BMI chorych z „ma∏ymi” powik∏aniami ogólnymi i chorych bez powik∏aƒ
ogólnych. Istotne statystycznie by∏y ró˝nice w d∏ugoÊci trwania zabiegu operacyjnego, obserwowane pomi´dzy grupà chorych
z „du˝ymi” powik∏aniami chirurgicznymi, a grupà chorych bez powik∏aƒ chirurgicznych (p=0,01) oraz ró˝nice w d∏ugoÊci trwa-
nia zabiegu operacyjnego, obserwowane pomi´dzy grupà chorych z „ma∏ymi” powik∏aniami ogólnymi, a grupà bez powik∏aƒ
ogólnych (p=0,05).
W n i o s k i.  Prospektywne obserwacje chorych z rakiem ˝o∏àdka, poddanych zabiegom resekcyjnym z intencjà wyleczenia, upo-
wa˝niajà do nast´pujàcych wniosków: 1) Istotny wp∏yw na zwi´kszone ryzyko ogólnych i chirurgicznych powik∏aƒ poopera-
cyjnych ma stan histologiczny regionalnych w´z∏ów ch∏onnych (N1/N2), podwpustowa lokalizacja guza nowotworowego, wy-
soka wartoÊç BMI, wiek chorego, zakres i czas trwania zabiegu operacyjnego. 2) Wprowadzenie staplerów wp∏yn´∏o na
usprawnienie techniki operacyjnej, ale nie mia∏o istotnego wp∏ywu na zmniejszenie chirurgicznych powik∏aƒ pooperacyjnych.
3) ˚ywienie pozajelitowe stosowane w okresie pooperacyjnym mo˝e zwi´kszaç ryzyko powik∏aƒ ogólnych. 4) Kompleksowe
dzia∏ania zmniejszajàce ryzyko powik∏aƒ oko∏ooperacyjnych powinny zawieraç odpowiednià taktyk´ ˝ywieniowà przed-
i pooperacyjnà, profilaktyk´ antybiotykowà i przeciwzakrzepowà, racjonalizacj´ czasu operacji, onkologiczne uzasadnienie po-
szerzenia zabiegu o splenektomi´ i limfadenektomi´ D3, które zwi´kszajà ryzyko powik∏aƒ oraz dok∏adny monitoring okresu
pooperacyjnego, wymagajàcy znajomoÊci specyfiki zabiegu operacyjnego.
Key words: gastric cancer, surgery, postoperative complications, risk factors
S∏owa kluczowe: rak ˝o∏àdka, doszcz´tne leczenie chirurgiczne, powik∏ania pooperacyjne – czynniki ryzyka
with the upper median incision usually extended below the
umbilicus.
After careful assessment the following steps were
performed: total or subtotal gastrectomy together with the major
and minor omentum, lymphadenectomy of groups 1-12 and the
restoration of the continuity of the digestive tract. In case of
total gastrectomy the restoration of the continuity of digestive
tract was obtained with the following methods:
1) „omega” – anastomosis of the oesophagus with the first
intestinal loop „end-to-side”, pre-colonic, with a “side-to-
side” enteroanastomosis of the afferent and efferent arms
of the loop (the Braun enteroanastomosis);
2) „un cut Roux” – „omega”-type anastomosis with stapler
suturation of the afferent intestinal loop;
3) „Roux-en-Y” anastomosis of the oesophagus with an isolated
intestinal loop „end-to-side”, usually pre-colonic, covering
the oesophago-jejunal anastomosis with the free end of the
loop (hemiplication). The osophageo-intestinal anastomosis
was hand sutured with two layers of sutures (layer 1 –
continuous suture, layer 2 – interrupted sutures) or – more
often – with a circular stapler. The stapler anastomosis was
reinforced with interrupted sutures all around and the
oesophago-jejunal anastomosis was suspended with
interrupted sutures to the peritoneal recess.
In case of sub-total gastrectomy the gastric stump was
anastomosed to the first small intestine loop modo Billroth, pre-
colon, with formation of the Braun enteroanastomosis. The
anastomosis was hand sutured with two layers of sutures or – less
commonly – with a stapler. The gastric stump was narrowed by
hand or with a linear stapler. The duodenal stump was closed
using one of the following techniques: 1) by hand, two layers
of sutures, 2) with a linear stapler – one staple level, 3) with
a linear staple – two staple levels 0.5 cm apart 4) with a linear
staple secured with an additional level of hand sutures.
In case of total gastrectomy we either performed a nutri-
tional jejunostomy or introduced a naso-jejunal feeding tube.
Peritoneal drainage was usually performed with two drains
– one in the vicinity of the duodenal stump, and another near the
oesophago-jejunal/gastro-jejunal anastomosis. In those cases
when splenectomy was performed another drain was left at the
splenectomy site.
Following factors were analyzed in the group of curative surgery
patients:
– age and gender,
– nutritional state – basing on body mass index (BMI), weight
loss, complete lymphocyte count (CLL), total protein and
albumin plasma concentration,
– the duration of surgery,
– clinico-pathological advancement stage according to TNM
classification (pTNM – basing on histopathological exami-
nation),
– regional lymph node status.
The analysis of suspected risk factors of perioperative
complications and perioperative mortality included:
– the type of operation and, in case of total gastrectomy, the
type of oesophago-jejunal anastomosis,
– the need for extending the procedure including resection of
other organs (splenectomy, partial liver resection, partial
pancreatic resection, partial colon resection, partial jejunal
resection, cholecystectomy),
– stapler use,
– nutrition support: pre- and postoperative – enteral and
parenteral.
The analysis of postoperative factors included:
Postoperative complications – with special respect to major
surgical complications: (leakage of the oesophago-jejunal
anastomosis, leakage of the duodenal stump),
– perioperative mortality
– overall 1-, 3-, 5-year mortality
All analysed complication risk factors were divided into two
categories:
– qualitative features
– quantitative features
Qualitative features included:
– gender
– TNM status
– tumour localisation
– range and type of gastrectomy
– the oesophago-jejunal anastomosis technique (in total
gastrectomy pts.),
– stapler use (for the oesophago-jejunal anastomosis),
– the need of performing additional surgical procedures,
– total parenteral nutrition (pre- and postoperative),
– enteral nutrition
Quantitative features included:
– age,
– body mass index (BMI),
– plasma protein concentration before surgery
– plasma albumin concentration before surgery
– duration of surgery
All observed complications were divided into 4 categories:
– major surgical complications
– minor surgical complications
– major general complications
– minor general complications
Subsequent statistical analysis of relationships of either
qualitative or quantitative measures and incidence of
complications was carried out and statistical analysis of the study
results was performed.
The statistical analysis included the assessment of influence
of qualitative or quantitative measures on the incidence of
complications (surgical or general) in the group of the curative
surgery patients.
To verify the hypothesis of the lack of relationship between
qualitative measures and complications the Chi2 test was used.
To verify the hypothesis of the lack of difference between
mean values of quantitative measures in groups of different
incidence of postoperative complications the one-way analysis of
variance was used based on the F test.
In the case of significant differences to identify the pairs of
means that differ significantly the multiple comparison test
based on minimal significant differences was used.
Results
The prospective follow-up of 253 gastric cancer patients
was performed from 1988 to 2001.
The detailed analysis was carried out in the group of
132 patients who had undergone curative surgery:
resectability was 52.2%. The latter group included 40
women (30.3%) and 92 men (69.7%). The mean age of
women was 58.8 yrs. (27–79), the mean age of men was
62.4 yrs. (44–78). The age groups of both genders are
presented in Table I.
The grade of advance of malignancy according to
TNM in the studied group is presented in Table II.
Complications were observed in 63 patients (47.7%).
Surgical complications were observed in 33 patients
(25%) including:
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– major surgical complications in 16 patients (12.1%),
– minor surgical complications in 17 patients (12.9%),
General complications were observed in 51 patients
(38.6%) including:
– major general complications in 13 patients (9.8%),
– minor general complications in 38 patients (28.8%).
The last group included 21 patients with concomitant
surgical and general complications - (15.9%).
The detailed concomitant surgical and general com-
plications analysis revealed the following “com-
binations”:
– major surgical complications + major general com-
plications in 2 patients (9.5%),
– major surgical complications + minor general
complications in 7 patients (33.3%),
– minor surgical complications + major general com-
plications in 3 patients (14.3%),
– minor surgical complications + minor general com-
plications in 9 patients (42.9%),
A characteristic of the complications is presented in
Table III.
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Table II. Gastric cancer stage in the analyzed group of 132 patients
according to the TNM classification
Stage TNM Classification No. of patients
I A T0N0M0 9
T1N0M0 10
I B T1N1M0 2
T2N0M0 13
II T2N1M0 1
T3N0M0 18
III A T2N2M0 1
T3N1M0 28
III B T4N0M0 2
T3N2M0 17
T4N1M0 7
IV T4N2M0 8
T3N1M1 3
T4N1M1 1
T3N2M1 4
T4N2M1 8
Table III. Type and number of complications. M1 feature – metastases (confirmed by pathology report) in lymphatic nodes of the hepatoduodenal
ligament, retropancreatic, mesenteric or periaortic lymph nodes and, in 1 case – a metastatic tumour in the small bowel wall
Character of complication Type of complication No of cases
"major" surgical – duodenal stump leakage 4
– subdiaphragmatic oesophago-jejunal anastomosis leakage 7
– thoracic oesophago-jejunal anastomosis leakage 2
– haemorrhage from upper gastrointenstinal tract 2
– perforation of duodenal ulcer 1
total 16
“minor” surgical – suppuration of postoperative wound 4
– post-drain suppuration 10
– peritoneal effusion 1
– reaction after venous puncture 6
total 21
Total: surgical complications 37
“major” general – DIC 1
– dysrrhythmias + acute cardiac ichaemia 5
– myocardial infarct 1
– cardiac arrest 1
– stroke 1
– ventilatory insufficiency 2
– kidney failure 1
– pancreatitis 1
total 13
“minor” general – fever 29
– atelectasis 5
– pneumonia 6
– acute bronchitis 1
– “reactive” pleural effusion 12
– diarrhoea 1
total 58
Total: general complications 71
Grand total 108
Table I. Age distribution in the analyzed group of 132 patients
according to gender
Age range (years) Women Men
< 30 1
30 – 40 5
41 – 50 3 10
51 – 60 12 29
61 – 70 10 38
> 70 9 15
Total 40 92
The most commonly observed complications (more
than 50%) were minor general complications (53,7% of
all complications), whereas the incidence of major surgical
complications was 14.8%.
Desuturation of the oesophegeo-jejeunal anasto-
mosis was observed in 9 patients (6.8%).
Postoperative mortality was 5.3%; 4 patients (76, 67,
74 and 78 years) died due to cardiac complications, 1
patient (69 years) – due to peritonitis resulting from ulcer
perforation of the duodenal stump, 1 patient (49 years) –
due to respiratory failure resulting from the desuturation
of the oesophegeo-jejeunal anastomosis (within the
thorax), 1 patient (61 years) – due to DIC in the course of
desuturation of the oesophago-jejunal anastomosis
(subdiaphragmatic).
All deaths were observed after total gastrectomy,
mainly in patients in the 7th and 8th decade of life, with
cardiac comorbidity. No death was observed after subtotal
gastrectomy.
The analysis of overall 1-, 3-, 5-year survival
according to histopathology revealed the following results:
in early cancer 1- and 3-year survival was 100%, 5-year
survival was 60%.
In advanced cancer 1-, 3-, 5-years survival was 79%,
47% and 30.5%, respectively.
In the whole group of patients the 1-, 3-, 5-year
survival was 80.5%, 51% and 32%, respectively.
The values are presented on Figure 1.
The analysis of overall 1-, 3-, 5-years survival
according to clinical advancement (TNM classification) is
presented on Figure 2.
D e t a i l e d  a n a l y s i s
Qualitative factors
1. Gender
The study group included 40 women (30.3%) and 92 men
(69.7%). The influence of gender on the incidence of
both surgical and general complications was statistically
nonsignificant. P value was for 0.45 for surgical and 0.17
for general complications, respectively.
2. T status
The size of the tumor did not significantly influence the
incidence of surgical complications (p=0.62).
The highest number of surgical complications was obser-
ved in patients from the T3 group (minor in 10 pts., major
in 8 pts.) but this group was the largest one (70 pts.).
In T0 group – (9 pts.; 6.8% of the analyzed group) minor
surgical complications were observed in 2 pts., and no
major complication was observed.
In the T1 group (12 pts.) we observed 1 minor and 1
major complication; in the T2 group (15 pts.) – 2 minor
and no major complications; in the T4 group (26 pts.) – 4
minor and 5 major complications.
Similar trends were observed for general complica-
tions. The relationship between the T feature and the
incidence of complication is statistically non-significant
(p=0.28).
3. N status
The incidence of surgical complication was higher in pts.
with nodal involvement (N1 and N2) than in the N0
group. Minor and major surgical complications were
observed in 9 cases from the N0 group, and in 24 cases
from the N1+ N2 group. The difference was statistically
non-significant (p=0.32).
Minor general complications were observed in 11 pts.
from the N0 group and in 27 pts. from the N1/N2 group,
and major general complications were observed in 5 pts.
from the N0 group and in 8 pts. from the N1/N2 group.
The incidence of general complications between the N0
and the N1/N2 groups reaches statistical significance
(p=0.02) (Figure 3).
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Figure 2. Overall 1-, 3-, and 5-year survival in gastric cancer patients
undergoing curative resection according to the stage in TNM
classification
Figure 1. Overall 1-, 3-, and 5-year survival in gastric cancer patients
undergoing curative resection according to histological type of tumour
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Figure 3. Distribution ranges illustrating the relations between lymph
node involvement and the incidence of general complications
4. M status
Among the 132 pts. who had undergone curative surgery
in 16 cases distant metastases were diagnosed (group
M1). In 6 of these pts. surgical complications were
observed – major in 3 cases and minor in 3 cases. In the
group without distant metastases (M0 group) major
surgical complications occurred in 14 patients, and minor
– in 13 pts. The influence of the M feature on the
incidence of surgical complications was statistically
insignificant (p=0.47).
We observed similar trends regarding general complica-
tions, especially minor complications: in the M0 group
complications were observed in 31 pts. (27%), and in the
M1 group in 7 pts. (as high as 43.8%). However, the
influence of the M feature on the incidence of general
complications was statistically insignificant (p=0.19).
5. Tumour localization
The following tumour locations were distinguished:
the cardia (the vicinity of the oesophago-gastric junc-
tion), the corpus, the pylorus, the entire stomach and
gastric stump after prior resection.
The tumour localization had no significant influence on
the incidence of surgical complications. (p=0.17).
However in case of general complications the highest
incidence was noted in pts. with tumours localized in the
upper corpus of the stomach – 7 pts. with major compli-
cations (53.8%) and 18 pts. with minor complication
(48.6%). General complications were more prevalent in
pts. with subcardial tumour location (p=0.01) (Figure 4).
6. Range and type of gastrectomy
In the analysed group of 132 patients who had undergone
curative surgery the following techniques were applied:
total gastrectomy in 77 cases, subtotal gastrectomy in 44
cases, resection of the cardia (i.e. resection of the upper
part of stomach and 1/3 lower part of oesophagus with
gastro-oesophageal anastomosis within the thorax cavity)
in 6 cases and total gastrectomy combined with resection
of 1/3 lower part of oesophagus with oesophago-jejunal
anastomosis within the thorax cavity in 5 cases. Surgical
complications, both major (9pts, 52.9%) and minor (10
pts. 62.5%) were more prevalent in the total gastrectomy
group as compared to the cardia excision and subtotal
gastrectomy.
The difference of surgical complication incidence between
the total gastrectomy group and the other groups is
statistically significant (p=0.05) (Figure 5).
The general complication incidence rate did not
relate to the type of surgery (p=0.83).
7. The type of oesophago-jejunal anastomosis
In case of total gastrectomy the continuity of the digestive
tract was restored with the following methods: Roux-en-Y
(46 pts.), ”omega” method (31 pts.) and "un cut Roux"
method (5 pts.).
No significant relationship was found between type
of oesophago-jejunal anastomosis and surgical or gene-
ral complications incidence (p=0.84 and p=0.59,
respectively).
8. Oesophago-jejunal anastomosis: manual anastomosis
versus circular stapler:
Both types of anastomosis carry the risks of all surgical
anastomotic complications, especially the major ones
(desuturation of the anastomosis).
The difference between the incidence of complications
(manual anstomosis: 15 pts. – 7 major, 8 minor; stapler
anastomosis: 18 pts. – 8 major and 10 minor) was not
statistically significant (p=0.066).
9. Concomitant additional procedures
Concomitant surgery was performed in 50 pts. In 36 pts 1
additional procedure was carried out, in 12 pts. – 2
additional procedures, and in 2 other patients – 3
additional procedures. The additional procedure was
splenectomy in 33 cases (in 12 cases together with other
additional procedures, usually partial pancreatectomy),
cholecystectomy in 18 cases, partial pancreatectomy
(resection of body/tail of the pancreas) in 6 cases, 2 cases
of partial liver resection (left lobe), 2 cases of jejunal
resection, 2 cases of colonal resection, 1 case of partial
diaphragm resection, 1 case of ovariectomy, 1 case of
femoral hernioplasty.
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Figure 4. Distribution ranges illustrating the relations between tumour
localization and the incidence of general complications
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Figure 5. Distribution ranges illustrating the relations between the
range of gastric resection and the incidence of surgical complications
No significant difference was observed the incidence
of surgical (15/50 versus 18/82; p=0.15) or general (23/50
versus 28/82; p=0.39) complications between the patients
with concomitant additional procedures and the
remaining patients.
The general complication incidence in the splenec-
tomy group was higher (26/33) as compared to the rest of
the patients undergoing additional procedures.
10. Preoperative parenteral nutrition
Preoperative Total Parenteral Nutrition (TPN) was
administered to 21 pts. The inclusion criteria for preope-
rative TPN were: marked weight loss (10% and more of
the ideal body weigh; in the studied group mean weight
loss was 13%, range 3-45%), plasma protein concen-
tration below 6.0 g%, plasma albumin concentration
below 2.8 g% and total lymphocyte count below 1.5 G/L.
Preoperative TPN was mainly administered in the years
1988-1995. In the later period preoperative parenteral
nutrition was replaced (whenever possible) with natural
nutrition enhanced with ready-made industrial prepa-
rations.
The number of surgical complications among
patients who had not received preoperative TPN was
higher than in patients, who did receive it (27/111 versus
6/21), however this difference does not achieve statistical
significance (p=0.12). We observed a similar situation in
the case of general postoperative complications (42/111
versus 9/21), where the difference also failed to reach
statistical significance (p=0.75).
11. Postoperative TPN
Postoperative TPN was administered to 92 patients. –
mainly those, who had undergone total gastrectomy or
who had developed postoperative complications
necessitating nutritional treatment (leakage of the
duodenal stump or of the oesophago-jejunal anasto-
mosis).
Thus, in this group the incidence of surgical complications
is higher in this group than in the group of patients who
did not receive postoperative TPN (28/92 versus 5/40),
however, this difference fails to reach statistical
significance (p=0.08).
As for the incidence of general complications among
patients who did not receive TPN – they were observed in
10 cases – 6 pts. with "major" complications and 4 patients
with "minor" complications. Among patients who had
received TPN we observed complications in 41cases: 34
"minor" complications, and 7 "major" complications.
Statistical analysis has shown, that postoperative
parenteral nutrition significantly influences the incidence
of general complications (p=0.0057).
12. Enteral nutrition
Postoperative enteral nutrition (EN) was administered
to 40 pts. (30.3%) with either a nutritional jejunostomy or
with a naso-jejunal feeding tube.
Surgical complications occurred in 13 of these
patients (32.5%): in 8 cases “major” and in 5 pts. “minor”.
General complications occurred in 23 pts. on enteral
nutrition (57.5%), in 5 cases “major” and in 18 cases
“minor”.
The statistical analysis has shown, that EN admi-
nistered during the postoperative period significantly
influences the incidence of general complications
(p=0.01).
Quantitative factors
1. Age
The mean age of the patients who had undergone curative
gastric surgery was 61.3 yrs.
The mean age of patients with surgical complications
was: 62.8 yrs. in case of the “minor” complications group
and 60.8 yrs. for the “major” complications group – the
difference was non-significant.
The mean age of the patients with general complications
was: 59.1 yrs. in the “minor” complications group and
67.0 yrs. in the “major” complications group – the
difference was statistically significant (p=0.05), in contrast
to the groups mentioned above.
2. Body Mass Index (BMI)
Mean value of Body Mass Index in all patients
undergoing curative surgery was 24.8 kg/m2.
The mean BMI of the patients with surgical complications
was: 27.7 kg/m2 in the “minor” complications group and
24.4 kg/m2 in the “major” complications group. In patients
free of surgical complications BMI was 24.4 kg/m2. The
difference of BMI between the “minor” surgical com-
plications group and the free of surgical complications
group was statistically significant (p=0.05).
The mean BMI of the patients with general
complications was: 26.1 kg/m2 in the “minor” com-
plications group and 24.3 kg/m2 in the “major” complica-
tions group. In patients free of general complications
BMI was 23.9 kg/m2. The difference of BMI between the
“minor” general complications group and the free of
general complications group was statistically significant
(p=0.05), as in the case of surgical complications.
3. Plasma protein concentration before surgery
Plasma protein concentration before surgery in all
the patients undergoing curative surgery was 6.59 g%
(4.6-8.4).
The mean plasma protein concentration in the
patients with surgical complications was: 6.49 g% (5.6-
7.8) in the “minor” complications group, 6.47 g% (5.0-7.8)
in the “major” complications group and 6.63 g% (5.2-
7.7) in the free of surgical complications group.
The mean plasma protein concentration in patients
with general complications was: 6.46 g% (4.6-8.3) in the
“minor” complications group, 6.73 g% (5.8-8.4) in the
“major” complications group and 6.67 g% (5.2-7.7) in
the free of general complications group.
The difference of plasma protein concentration
before surgery in both the surgical complications group
and general complications group was non-significant.
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4. Plasma albumin concentration before surgery
Plasma albumin concentration before surgery in all the
patients undergoing curative surgery was 3.68 g% (2.3-
5.2).
The mean plasma albumin concentration in patients
with surgical complications was: 3.88 g% (3.4-4.6) in the
“minor” complications group, 3.73 g% (2.6-4.8) in the
“major” complications group and 3.63 g% (2.3-5.2) in
the free of surgical complications group.
The mean plasma albumin concentration in patients
with general complications was: 3.56 g% (2.3-4.6) in the
“minor” complications group, 3.84 g% (2.7-5.2) in the
“major” complications group and 3.75 g% (2.7-4.8) in
the free of general complications group.
The difference of plasma albumin concentration
between pts with and without complications in both the
surgical and general complication groups were non-
significant.
5. Duration of surgery
The mean duration of surgery in the studied group was
248 min.
The mean duration of surgery in the patients with surgical
complications was: 263 min in the “minor” complications
group and 288 min in the “major” complications group.
The mean duration of surgery in the patients without
surgical complications was 238 min.
The difference of the mean duration of surgery
between the “major” surgical complications group and
the free of surgical complications group was statistically
significant (p=0.01).
The mean duration of surgery in the patients with
general complications was: 265 min in the “minor”
complications group and 251 min in the “major” com-
plications group. The mean duration of surgery in the
patients without general complications was 234 min.
The difference of the mean duration of surgery
between the “major” general complications group and
the free of general complications group was also
statistically significant (p=0.05).
Discussion
Despite the development of diagnostic methods, espe-
cially visualisation techniques and endoscopy, initial
diagnosis still remains the basic problem in gastric cancer.
Early diagnosis directly influences the curability – which
may be as high as 90%. In Poland early gastric cancer
(limited to the mucous and submucous membranes) is
diagnosed only in a few percent of patients undergoing
surgical procedures with a curative intent. In Western
European Countries and in the US this ratio reaches
some 15%, while in Japan – as much as 50-65% [1-3].
In our material – 132 patients with gastric cancer in
whom we performed radical operations with curative
intent – early gastric cancer was found in 9 pts. (i.e. 6.8%).
The remaining patients (93.2%) had more advanced
stages of the disease, usually III0 (55 pts. – 41.7%) and
IV0 (24 pts. – 18.2%).
The ratio of patients undergoing radical resection
(resectable) reaches 50-60% in Polish material [4, 5]. We
observed this also in our group with 52.2% of radical
resections (as in the 1988-2001 time lapse).
Patients with gastric cancer radical surgery
(especially in the form of total gastrectomy) present with
a relatively high risk of postoperative complications and
postoperative mortality [6-16].
In Western European countries in the late seventies
postoperative mortality in cases of total gastrectomy
reached, approximately, 30%. In the eighties it fell to
10% and recently it is seldom reported to exceed 5%. In
Poland recently it is reported not to exceed 10% [17, 18].
In our group of patients the postoperative mortality rate
was 5.3% (i.e. 7/132).
According to literature data the ratio of post-
operative complications after total gastrectomy may be as
high as 50-60%, especially in patients in the 7th and 8th
decade of life. The ratio of the one complication which is
the main cause of postoperative mortality – desuturation
of anastomosis – reaches 20% [9, 14, 16, 19]. We observed
postoperative complications in 63 patients (47.7%), with
anastomosis leakage in 9 patients (6.8%).
Total or subtotal gastrectomy with accompanying
lymphadenectomy remains the method of choice in the
treatment of both early and advanced gastric cancer. It is
therefore all the more important to attempt to improve
the results of these procedures – especially to decide
upon the factors and treatment methods which would
allow to limit the risk of postoperative complications [9,
20]. In this paper we have presented such an analysis of
a number of factors and techniques which appear at
different moments throughout treatment – before, during
and after surgery. Our analysis covered both characteristic
features on the part of the patients and the applied
methods themselves.
The patient characteristics which, according to our
material, seem to influence directly the ratio of post-
operative complications are age and BMI.
Age had significant influence (p=0.05) as a factor
which increased the risk of general complications during
the postoperative period, which we refer to as “major”, as
compared to the complications referred to as “minor”,
in the case of which age did not have such a significant
impact. Patients in whom we had observed “major”
general complications were older (on average by 8 years –
mean age in this group of patients being 67 years) than
patients with “minor” general complications. This
correlates with literature reports [12, 14]. In these papers
the authors present patients in the 7th and 8th decade of
life who had undergone radical surgery for gastric cancer
and stress the significant impact of patient age upon
ventilatory and circulatory complications. This is
undoubtedly caused by the postoperative state of the
patients’ cardiovascular and pulmonary health [12]. In
our study group the greater part of major complications
did also arise from cardiovascular and pulmonary
problems (myocardial ischaemia, myocardial infarct,
dysrrhythmias, ventilatory insufficiency).
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The BMI was an independent risk factor of both
surgical and general complications, which we have
referred to as “minor”. The mean BMI value in patients
with “minor” surgical complications was 27.7, while in
patients with “minor” general complications this value
was 26.1. Mean BMI value of patients in whom no
complications were observed was 24, and was significantly
lower (p=0.05). One may therefore expect, that if
a patient with gastric cancer scheduled for radical surgery
has BMI value >27 the postoperative risk ratio is
significantly higher (e.g. problems with wound healing).
We would like to emphasize the fact that in our
patients preoperative parenteral nutrition decreased the
risk of postoperative complications although the negative
effects of hyperalimentation are becoming a common
subject of investigations and literature reports [21-23].
Gastric cancer manifests itself through a number of
features, among them impaired nutritional status. In the
course of clinical observations it has been estimated that
some 50-60% of patients qualified for surgical treatment
of malignancies of the upper alimentary tract are in need
of preoperative nutritional treatment. Metabolic disorders
arising from the development of the oncological diseases
aggravate due to the surgical trauma, which significantly
increases the patient’s catabolism, thus using up energy
sources and increasing the risk of grave postoperative
complications [24-28]. In our group of patients the mean
preoperative loss of body mass reached 13% (3-45%),
i.e. a mean value of 8 kg (2-25 kg) and was observed in
33% of the patients. The loss of 10% of ideal body mass is
an indication for nutritional treatment [21-23, 25-28].
One may presume that in the examined group of patients
the administration of preoperative parenteral nutrition
equaled the chances of malnourished patients without
causing any complications arising from intravenous
nutritional treatment.
In our group of patients the most important factors
increasing the risk of postoperative complications were:
the regional lymph node status (p=0.02); tumour
localization (p=0.01) the range and type of gastric
resection (p=0.05), the method of performing the
oesophago-jejunal anastomosis (p=0.01) and the duration
of the surgical procedure (p=0.05).
In the examined group the characteristics of the
malignant tumour (size, rate of infiltration) did not affect
the risk of postoperative complications, as has also been
reported by other authors [20]. The depth of infiltration
and the expression of some substances within the
malignant tissue (protein p53, oncogene c-erbB2, E-
cadherin, β-catenin etc) pose as risk factors connected
to the risk of local nodal metastases, dissemination and
survival [29-37].
The N feature significantly influenced the ratio of
general complications, which were more common
(p=0.02) in N1/N2 patients, as compared to N0 patients.
This is probably related to the range of regional lymph
node dissection and, thus, to the duration of the surgical
procedure. The range of lymph node dissection and its
impact on postoperative mortality and morbidity is still
being widely discussed in literature [6-8, 10, 38-46].
We have also observed a significant influence of the
localization of the tumour on the increase of the risk of
general complications. The risk was higher (p=0.01) in
the case of tumours localized in the upper part of the
body of the stomach. This phenomenon probably arises
from the possibility of infiltration of neighbouring organs
– the tail of the pancreas, the spleen, the left hepatic
lobe), more common in this case of tumour localization.
Therefore, in such cases, the range of resection and the
duration of the procedure have to be increased [11, 47,
48].
The range and type of gastric resection also
influences the postoperative risk ratio. In our group of
patients total gastrectomy significantly (p=0.05) increased
the risk of both “major” and “minor” surgical com-
plications. Similar data may be found in literature [19,
49-52]. We observed no differences arising from the
technique of anastomosis (sutured by hand or mecha-
nically) although some authors report mechanical
suturation to be safer [19, 53].
Simultaneous additional procedures were performed
in 50 patients (38%), of these splenectomy accounted for
33 cases. A majority of complications observed in this
group of patients (both surgical and general) were
reported in the splenectomy patients (26/33 i.e. 79%).
Literature reports present similar results – splenectomy is
reported to be an independent risk factor of postoperative
complications in patients undergoing total gastrectomy
for gastric cancer [54]. In our material splenectomy was
such an important factor not only due to the excision of
“the largest lymph node”, but also because in 12 cases
splenectomy was accompanied by yet another additional
procedure – usually with partial resection of the pancreas
(6 patients).
An important factor affecting the risk of
postoperative complications was the duration of surgery.
The differences in procedure duration between patients
with “major” surgical complications and “minor” general
complications reached statistical significance when
compared to procedure duration in patients in whom no
such complications were reported (p=0.05). Similar data
may be found in literature [12].
Parenteral nutrition may have a significant impact on
the course of the postoperative period, including the
complications ratio. In our material we observed the
influence of parenteral nutrition on the increased risk of
general complications. The difference in the frequency
of these complications in the group of patients receiving
parenteral nutrition in the preoperative period and in
the group of patients without parenteral nutrition is
statistically significant (p=0.0057); similar observations
may be made when analyzing patients on postoperative
enteral nutrition (p=0.01), This latter feature may arise
from the fact that the latter group of patients includes
those with complications necessitating intensive
nutritional treatment (e.g. anastomosis dehiscence) who
are in need of lengthy treatment and long hospitalization.
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Basing upon these results we may conclude, that
some of the factors increasing the risk of postoperative
complications are found on the part of the patient –
obesity, age, advance of disesase (N-stage) and tumour
localization. The character of the malignancy also
determines the range and type of surgery – one cannot
discuss the indications for radical gastrectomy or for
increasing the range of excision to include other
infiltrated organs if such is the intraoperative necessity
and there exists a possibility of performing a radical
operation.
On the other hand the factors on which the surgeon
does have some influence when undertaking surgical
treatment with a curative intent in the case of a patient
with gastric cancer include improving the nutritional
status of the patient in the preoperative period, correct
qualification for nutritional treatment, perfecting surgical
techniques (incl. the correct choice of operation) and,
during the postoperative period, close scrutiny and care of
the patient with adequately chosen pharmacological and
nutritional treatment.
Conclusions
The prospective observation of gastric cancer patients
undergoing resection with a curative intent has brought us
to the following conclusions:
1. The factors which significantly influence the risk of
both general and surgical postoperative complications
include the histopathological status of the regional
lymph nodes (N1/N2), subcardial localization of the
tumour, high BMI, advanced age and the range and
duration of surgery.
2. The introduction of staplers has improved the surgical
technique, but it has not decreased the ratio of
postoperative complications.
3. Postoperative parenteral nutrition may increase the
risk of general complications.
4. In order to decrease the ratio of complications
a complex approach is necessary – including a correct
approach to pre-and postoperative nutritional treat-
ment, prophylaxis with antiobiotics and anticoagulants,
rational choice of time for surgery, oncological
indications for splenectomy and D3 lymphadenectomy
(which significantly increase the risk ratio) and careful
postoperative monitoring which demands a good
understanding of the surgical specificities.
Prof. Stanis∏aw G∏uszek MD, PhD
Loefflera 17 Str.
25-550 Kielce
Poland
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